{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:18:49Z","timestamp":1761128329572},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1995,11,1]],"date-time":"1995-11-01T00:00:00Z","timestamp":815184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1995,11]]},"DOI":"10.1007\/bf01691379","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T02:17:19Z","timestamp":1116123439000},"page":"972-978","source":"Crossref","is-referenced-by-count":13,"title":["Activity of beta-lactamase inhibitor combinations onEscherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents"],"prefix":"10.1007","volume":"14","author":[{"given":"D.","family":"Vanjak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Muller-Serieys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Picard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bergogne-Berezin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Lambert-Zechovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01691379_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/oxfordjournals.bmb.a071942","volume":"40","author":"AA Medeiros","year":"1984","unstructured":"Medeiros AA: Beta-lactamases. British Medical Bulletin 1984, 40: 18\u201327.","journal-title":"British Medical Bulletin"},{"key":"BF01691379_CR2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/AAC.29.6.980","volume":"29","author":"MR Jacobs","year":"1986","unstructured":"Jacobs MR, Aronoff SC, Johenning S, Shlaes DM, Yamabe S: Comparative activities of the \u03b2-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined \u03b2-lactamase producing aerobic gramnegative bacilli. Antimicrobial Agents and Chemotherapy 1986, 29: 980\u2013985.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01691379_CR3","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/AAC.33.11.1964","volume":"33","author":"NV Kuck","year":"1989","unstructured":"Kuck NV, Jacobus PJ, Petersen PJ, Weiss WJ, Testa RT: Comparative in vitro and in vivo activities of piperacillin combined with the \u03b2-lactamase inhibitors tazobactam, clavulanic acid and sulbactam. Antimicrobial Agents and Chemotherapy 1989, 33: 1964\u20131969.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement B","key":"BF01691379_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/9.suppl_B.11","volume":"9","author":"JMT Hamilton-Miller","year":"1982","unstructured":"Hamilton-Miller JMT: Beta-lactamases and their clinical significance. Journal of Antimicrobial Chemotherapy 1982, 9, Supplement B: 11\u201319.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01691379_CR5","first-page":"741","volume":"41","author":"J Acar","year":"1993","unstructured":"Acar J, Bergogne-Berezin E, Brognard JM, Chabbert Y, Cluzel R, Courvalin P, Dabernat H, Drugeon H, Dubreuil L, Duval J, Flandrois JP, Goldstein F, Meyran M, Morel CI, Philippon A, Sirot J, Thabaut A: Communiqu\u00e9 1993 du Comit\u00e9 de l'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Pathologie Biologie 1993, 41: 741\u2013748.","journal-title":"Pathologie Biologie"},{"key":"BF01691379_CR6","first-page":"1969","volume":"88","author":"M Mathew","year":"1975","unstructured":"Mathew M, Harris AM, Marshall MJ, Ross GW: Use of analytical isoelectric focusing for detection and identification of \u03b2-lactamases. Journal of General Microbiology 1975, 88: 1969\u20131978.","journal-title":"Journal of General Microbiology"},{"key":"BF01691379_CR7","first-page":"295","volume":"130","author":"R Labia","year":"1979","unstructured":"Labia R, Barthelemy M: L'enzymogramme des \u03b2-lactamases: adaptation en gel de la m\u00e9thode iodom\u00e9trique. Annales de Microbiologie 1979, 130B: 295\u2013304.","journal-title":"Annales de Microbiologie"},{"key":"BF01691379_CR8","volume-title":"BMDP. Statistical Software","author":"W Dixon","year":"1981","unstructured":"Dixon W: BMDP. Statistical Software, University of California Press, Berkeley, 1981."},{"key":"BF01691379_CR9","first-page":"113","volume":"91","author":"CJ Thomson","year":"1992","unstructured":"Thomson CJ, Amyes SJB: TRC-1. Emergence of clavulanic acid-resistant TEM-\u03b2-lactamase in a clinical strain. FEMS Microbiology Letters 1992, 91: 113\u2013118.","journal-title":"FEMS Microbiology Letters"},{"key":"BF01691379_CR10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jac\/30.4.449","volume":"30","author":"G Vedel","year":"1992","unstructured":"Vedel G, Belaaouaj A, Gilly L, Labia R, Philippon A, Nevot P, Paul G: Clinical isolates ofEscherichia coli producing TRI \u03b2-lactamases, novel TEM-enzymes conferring resistance to \u03b2-lactamase inhibitors. Journal of Antimicrobial Chemotherapy 1992, 30: 449\u2013462.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01691379_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01644127","volume":"15","author":"A Bauernfeind","year":"1987","unstructured":"Bauernfeind A, H\u00f6rl G: Novel R-factor borne \u03b2-lactamase ofEscherichia coli conferring resistance to cephalosporins. Infection 1987, 15: 257\u2013259.","journal-title":"Infection"},{"key":"BF01691379_CR12","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0140-6736(87)91180-9","volume":"ii","author":"JL Martinez","year":"1987","unstructured":"Martinez JL, Cercenado E, Rodriguez-Creixems M, Vicente-Perez MF, Delgado-Iribarren A, Baquero F: Resistance to \u03b2-lactam\/clavulanate. Lancet 1987, ii: 1473.","journal-title":"Lancet"},{"key":"BF01691379_CR13","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/AAC.37.10.2059","volume":"37","author":"J Blazquez","year":"1993","unstructured":"Blazquez J, Baquero MR, Canton R, Alos I, Baquero F: Characterization of a new TEM-type \u03b2-lactamase resistant to clavulanate, sulbactam and tazobactam in a clinical isolate ofEscherichia coli. Antimicrobial Agents and Chemotherapy 1993, 37: 2059\u20132063.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01691379_CR14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/AAC.38.5.1085","volume":"38","author":"XY Zhou","year":"1994","unstructured":"Zhou XY, Bordon F, Sirot D, Kitzis MD, Gutmann L: Emergence of clinical isolates ofEscherichia coli producing TEM-1 derivatives or an OXA-1 \u03b2-lactamases conferring resistance to \u03b2-lactamase inhibitors. Antimicrobial Agents and Chemotherapy 1994, 38: 1085\u20131089.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01691379_CR15","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1128\/AAC.34.11.2200","volume":"34","author":"GA Papanicolaou","year":"1990","unstructured":"Papanicolaou GA, Medeiros AA, Jacoby GA: Novel plasmid-mediated \u03b2-lactamase (MIR-1) conferring resistance to oxyimino and \u03b1-methoxy \u03b2-lactams in clinical isolates ofKlebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 1990, 34: 2200\u20132209.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01691379_CR16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.34.5.739","volume":"34","author":"R Cooksey","year":"1990","unstructured":"Cooksey R, Swenson J, Clark N, Gay E, Thornsberry C: Patterns and mechanisms of \u03b2-lactam resistance among isolates ofEscherichia coli from hospitals in the United States. Antimicrobial Agents and Chemotherapy 1990, 34: 739\u2013745.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01691379_CR17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/AAC.32.9.1365","volume":"32","author":"CC Sanders","year":"1988","unstructured":"Sanders CC, Laconis JP, Bodey GP, Samonis G: Resistance to ticarcillin-potassium clavulanate among clinical isolates of the familyenterobacteriaceae: role of PSE-1 \u03b2-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrobial Agents and Chemotherapy 1988, 32: 1365\u20131369.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01691379_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0399-077X(05)80510-4","volume":"23","author":"F Fitoussi","year":"1993","unstructured":"Fitoussi F, Arlet G, Casin I, Lagrange Ph, Philippon A: Activit\u00e9 inhibitrice de diff\u00e9rentes concentrations d'acide clavulanique, de tazobactam et de sulbactam vis \u00e0 vis de 117 souches d'ent\u00e9robact\u00e9ries productrices de \u03b2-lactamase. M\u00e9decine et Maladies Infectieuses 1993, 23: 3\u201321.","journal-title":"M\u00e9decine et Maladies Infectieuses"},{"key":"BF01691379_CR19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/CMR.1.1.109","volume":"1","author":"K Bush","year":"1989","unstructured":"Bush K: \u03b2-lactamase inhibitors from laboratory to clinic. Clinical Microbiology Reviews 1989, 1: 109\u2013123.","journal-title":"Clinical Microbiology Reviews"},{"key":"BF01691379_CR20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/27.6.761","volume":"27","author":"DM Livermore","year":"1991","unstructured":"Livermore DM, Seetulsingh P: Susceptibility ofEscherichia coli isolates with TEM-1 \u03b2-lactamase to combinations of BRL 42715, tazobactam or clavulanate with piperacillin or amoxicillin. Journal of Antimicrobial Chemotherapy 1991, 27: 761\u2013767.","journal-title":"Journal of Antimicrobial Chemotherapy"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01691379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01691379\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01691379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T16:00:31Z","timestamp":1557244831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01691379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["BF01691379"],"URL":"https:\/\/doi.org\/10.1007\/bf01691379","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,11]]}}}